Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

July 17, 2023

PRESS RELEASE: Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab) Twice a Year, 10-Minute Subcutaneous Injection in Patients With Multiple Sclerosis

  • Marketing
    /
 Wednesday, Jul 12, 2023 Phase III OCARINA II trial met primary and secondary endpoints   Ocrevus 10-minute injection has the…
Marketing

July 13, 2023

Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab)

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Positive Results Announced from Phase 3 OCARINA II…
MS Drug Therapies

July 5, 2023

Invisible symptoms: the unseen side of MS

  • Additional MS resource sites
    /
  • Multiple Sclerosis (MS) Symptoms
    /
6 June 2023 Many MS symptoms seem invisible to other people. They may affect you greatly but no one seems…
Additional MS resource sites

July 5, 2023

Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS – PubMed

  • NMO (NMOSD/Devics)
    /
  • Other Neuro Conditions
    /
 This is a PubMed Article: https://pubmed.ncbi.nlm.nih.gov/37402345/  Qiao Xu 1, Xixi Yang 1, Zhandong Qiu 1, Dawei Li 1, Hongxing Wang 1, Hong Ye 1, Lidong Jiao 1, Jing Zhang 1, Li Di 1, Peng Lei 2, Huiqing Dong 1, Zheng Liu 3 Affiliations expand PMID: 37402345…
NMO (NMOSD/Devics)

July 5, 2023

Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for MS – PubMed

  • Clinical Trials
    /
 https://pubmed.ncbi.nlm.nih.gov/37400245/ Gabriel Bsteh 1 2, Harald Hegen 3, Patrick Altmann 4 2, Michael Auer 3, Klaus Berek 3, Franziska Di Pauli 3, Barbara Kornek 4 2, Nik Krajnc 4 2, Fritz Leutmezer 4 2, Stefan Macher 4 2, Paulus Stefan Rommer 4 2, Karin Zebenholzer 4 2, Gudrun Zulehner 4 2, Tobias Zrzavy 4 2, Florian Deisenhammer 3, Berthold Pemp 5, Thomas…
Clinical Trials

July 5, 2023

Risk Factors for Multiple Sclerosis Development After Optic Neuritis Diagnosis Using a Nationwide Health Records Database

  • Clinical Trials
    /
 Henry C Skrehot 1, Anshul Bhatnagar 1, Austin Huang 1, Andrew G Lee   Affiliations expand PMID: 37398505   PMCID: PMC10312022 (available on 2024-02-16)   DOI: 10.1080/01658107.2023.2176891 Abstract Multiple sclerosis (MS) is an…
Clinical Trials

July 2, 2023

Tendonitis and MS: Are They Connected?

  • Misc. MS Related
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  Multiple sclerosis (MS) can cause a wide range of symptoms, including pain in the muscles and joints (musculoskeletal pain). On MyMSTeam, the…
Misc. MS Related

July 2, 2023

MS Bowel Problems: Ways To Manage Constipation and More

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Symptoms
    /
 Medically reviewed by Amit M. Shelat, D.O. Article written by  Victoria Menard The symptoms of multiple sclerosis (MS) can vary from person to person…
Multiple Sclerosis

June 27, 2023

Bad Diet = 10X more Multiple Sclerosis!

  • Additional MS resource sites
    /
  • Comorbidities
    /
  • Healthcare Perspectives
    /
  • Multiple Sclerosis
    /
  • Nutrition
    /
 Information provided by Brandon Beaber, MD Does diet affect MS?  According to a study in Jordan, people who scored the…
Additional MS resource sites

June 27, 2023

Review: Ocrevus best of 4 antibody therapies for progressive MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
 Drug found most effective also only one approved for PPMS by FDA by Steve Bryson, PhD | June 27, 2023 Among four antibody-based…
MS Drug Therapies

Categories

Latest Blog Posts